Incyte preps Jakafi expansion into graft-versus-host disease

Incyte preps Jakafi expansion into graft-versus-host disease

Source: 
Biopharma Dive
snippet: 

Incyte is gearing up for a Jakafi label expansion, announcing Thursday plans to submit the bone marrow drug to treat graft-versus-host disease in the third quarter.